Referências

1. Siegel R.L., Miller K.D., Jemal A., Cancer statistics, 2019, CA Cancer J Clin, 69, pp. 7-34, (2019)
2. Wittekindt C., Et al., HPV -a different view on head and neck cancer, Laryngorhinootologie, 97, pp. S48-S113, (2018)
3. Guo Y., Pang M.C.-Y., Teo C.E.-H., Chng J.K., Carotid artery involvement in advanced recurrent head and neck cancer: A case report and literature review, Ann Vasc Surg, 56, (2019)
4. Nemeth Z., Et al., Resection and replacement of the carotid artery in metastatic head and neck cancer: Literature review and case report, Int J Oral Maxillofac Surg, 32, pp. 645-650, (2003)
5. Kroeker T.R., O'Brien J.C., Carotid resection and reconstruction associated with treatment of head and neck cancer, Proc (Bayl Univ Med Cent), 24, pp. 295-298, (2011)
6. Atkinson D.P., Jacobs L.A., Weaver A.W., Elective carotid resection for squamous cell carcinoma of the head and neck, Am J Surg, 148, pp. 483-488, (1984)
7. Brennan J.A., Jafek B.W., Elective carotid artery resection for advanced squamous cell carcinoma of the neck, Laryngoscope, 104, pp. 259-263, (1994)
8. Luo C.-B., Teng M.M.-H., Chang F.-C., Chang C.-Y., Guo W.-Y., Radiation carotid blowout syndrome in nasopharyngeal carcinoma: Angiographic features and endovascular management, Otolaryngol Neck Surg, 138, pp. 86-91, (2008)
9. Ricco J.-B., Illuminati G., Belmonte R., [Resection of recurrent neck cancers with replacement of the carotid artery], J Med Vasc, 42, pp. 282-289, (2017)
10. Illuminati G., Et al., Resection of recurrent neck cancer with carotid artery replacement, J Vasc Surg, 63, pp. 1272-1278, (2016)
11. Caldarelli C., Ghilardi P., Matteucci F., Caramella D., A case of carotid artery resection and replacement in advanced laryngeal carcinoma, J Cardiovasc Surg, 49, pp. 773-776, (2008)
12. Sisson G.A., Goldman M.E., Pectoral myocutaneous island flap for reconstruction of stomal recurrence, Arch Otolaryngol, 107, pp. 446-449, (1981)
13. Kalani M.Y.S., Et al., Cerebral revascularization and carotid artery resection at the skull base for treatment of advanced head and neck malignancies, J Neurosurg, 118, pp. 637-642, (2013)
14. Amin M.B., Et al., The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging, CA Cancer J Clin, 67, pp. 93-99, (2017)
15. Freeman S.B., Hamaker R.C., Borrowdale R.B., Huntley T.C., Management of neck metastasis with carotid artery involvement, Laryngoscope, 114, pp. 20-24, (2004)
16. Nishinari K., Et al., Late surgical outcomes of carotid resection and saphenous vein graft revascularization in patients with advanced head and neck squamous cell carcinoma, Ann Vasc Surg, 28, pp. 1878-1884, (2014)
17. Mourad M., Saman M., Stroman D., Lee T., Ducic Y., Carotid artery sacrifice and reconstruction in the setting of advanced head and neck cancer, Otolaryngol Neck Surg, 153, pp. 225-230, (2015)
18. Zhang Y., Gao M., Li S., Excision of head and neck tumors combined with carotid artery resection without arterial blood vessel reconstruction, Clin Oncol Cancer Res, 6, pp. 286-289, (2009)
19. Back L.J.J., Et al., Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: Review and meta-analysis, Head Neck, 40, pp. 1305-1320, (2018)
20. Davila V.J., Et al., Current surgical management of carotid body tumors, J Vasc Surg, 64, pp. 1703-1710, (2016)
21. Drolet B.A., Esterly N.B., Frieden I.J., Hemangiomas in children, N Engl J Med, 341, pp. 173-181, (1999)
22. Enjolras O., Et al., Noninvoluting congenital hemangioma: A rare cutaneous vascular anomaly, Plast Reconstr Surg, 107, pp. 1647-1654, (2001)
23. Macarthur C.J., Head and neck hemangiomas of infancy, Curr Opin Otolaryngol Head Neck Surg, 14, pp. 397-405, (2006)
24. Mulliken J.B., Glowacki J., Hemangiomas and vascular malformations in infants and children:A classification based on endothelial characteristics, Plast Reconstr Surg, 69, pp. 412-422, (1982)
25. Frieden I.J., Eichenfield L.F., Esterly N.B., Geronemus R., Mallory S.B., Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee, J Am Acad Dermatol, 37, pp. 631-637, (1997)
26. Beck D.O., Gosain A.K., The presentation and management of hemangiomas, Plast Reconstr Surg, 123, pp. 181e-191e, (2009)
27. Metry D.W., Hebert A.A., Benign cutaneous vascular tumors of infancy: When to worry, what to do, Arch Dermatol, 136, pp. 905-914, (2000)
28. Haggstrom A.N., Et al., Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment, Pediatrics, 118, pp. 882-887, (2006)
29. Bruckner A.L., Frieden I.J., Hemangiomas of infancy, J Am Acad Dermatol, 48, pp. 476-477, (2003)
30. Adkinson J.M., Head and neck vascular anomalies: A practical case-based approach, Plast Reconstr Surg, 137, (2016)
31. Goldenberg D.C., Hiraki P.Y., Marques T.M., Koga A., Gemperli R., Surgical treatment of facial infantile hemangiomas: An analysis based on tumor characteristics and outcomes, Plast Reconstr Surg, 137, pp. 1221-1231, (2016)
32. Bauland C.G., van Steensel M.A.M., Steijlen P.M., Rieu P.N.M.A., Spauwen P.H.M., The pathogenesis of hemangiomas: A review, Plast. Reconstr. Surg, 117, pp. 29e-35e, (2006)
33. Blei F., New clinical observations in hemangiomas, Semin Cutan Med Surg, 18, pp. 187-194, (1999)
34. Orlow S.J., Isakoff M.S., Blei F., Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a ‘beard’ distribution, J Pediatr, 131, pp. 643-646, (1997)
35. Berenguer B., Et al., Rapidly involuting congenital hemangioma: Clinical and histopathologic features, Pediatr Dev Pathol, 6, pp. 495-510, (2003)
36. Osio A., Et al., Clinical spectrum of tufted angiomas in childhood: A report of 13 cases and a review of the literature, Arch Dermatol, 146, pp. 758-763, (2010)
37. Leaute-Labreze C., Et al., Propranolol for severe hemangiomas of infancy, N Engl J Med, 358, pp. 2649-2651, (2008)
38. Degardin-Capon N., Et al., [Early surgical treatment of cutaneous hemangiomas], Ann Chir Plast Esthet, 51, pp. 321-329, (2006)
39. Sacks D., Et al., Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke, Int J stroke, 13, pp. 612-632, (2018)
40. Brouillard P., Et al., Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (‘glomangiomas’), Am J Hum Genet, 70, pp. 866-874, (2002)
41. Limaye N., Et al., Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations, Nat Genet, 41, pp. 118-124, (2009)
42. Revencu N., Et al., RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation, Hum Mutat, 34, pp. 1632-1641, (2013)
43. Noe J.M., Barsky S.H., Geer D.E., Rosen S., Port wine stains and the response to argon laser therapy: Successful treatment and the predictive role of color, age, and biopsy, Plast Reconstr Surg, 65, pp. 130-136, (1980)
44. Soblet J., Limaye N., Uebelhoer M., Boon L.M., Vikkula M., Variable somatic TIE2 mutations in half of sporadic venous malformations, Mol Syndromol, 4, pp. 179-183, (2013)
45. Dompmartin A., Et al., Association of localized intravascular coagulopathy with venous malformations, Arch Dermatol, 144, pp. 873-877, (2008)
46. Seront E., Vikkula M., Boon L.M., Venous malformations of the head and neck, Otolaryngol Clin N Am, 51, pp. 173-184, (2018)
47. Bradley J.P., Zide B.M., Berenstein A., Longaker M.T., Large arteriovenous malformations of the face: Aesthetic results with recurrence control, Plast Reconstr Surg, 103, pp. 351-361, (1999)
48. Richter G.T., Suen J.Y., Clinical course of arteriovenous malformations of the head and neck: A case series, Otolaryngol Neck Surg, 142, pp. 184-190, (2010)
49. Leng T., Wang X., Huo R., Cheng Z., Feng Y., The value of three-dimensional computed tomographic angiography in the diagnosis and treatment of vascular lesions, Plast Reconstr Surg, 122, pp. 1417-1424, (2008)
50. Weinzweig N., Et al., Arteriovenous malformation of the forehead, anterior scalp, and nasal dorsum, Plast Reconstr Surg, 105, pp. 2433-2439, (2000)
51. Chen W., Ye J., Xu L., Huang Z., Zhang D., A multidisciplinary approach to treating maxillofacial arteriovenous malformations in children, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108, pp. 41-47, (2009)
52. Azzolini A., Bertani A., Riberti C., Superselective embolization and immediate surgical treatment:Our present approach to treatment of large vascular hemangiomas of the face, Ann Plast Surg, 9, pp. 42-60, (1982)
53. Wu J.K., Et al., Auricular arteriovenous malformation: Evaluation, management, and outcome, Plast Reconstr Surg, 115, pp. 985-995, (2005)
54. Kang G.C.W., Song C., Forty-one cervicofacial vascular anomalies and their surgical treatment--retrospection and review, Ann Acad Med Singap, 37, pp. 165-179, (2008)
55. Couto J.A., Et al., Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation, Am J Hum Genet, 100, pp. 546-554, (2017)
56. Greene A.K., Goss J.A., Vascular anomalies: From a clinicohistologic to a genetic framework, Plast Reconstr Surg, 141, pp. 709e-717e, (2018)
57. Narkio-Makela M., Et al., Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response, Eur Arch Oto-rhino-laryngol, 268, pp. 123-129, (2011)
58. Zhou Q., Et al., Treatment guidelines of lymphatic malformations of the head and neck, Oral Oncol, 47, pp. 1105-1109, (2011)
59. Breugem C.C., Courtemanche D.J., Portable ultrasound-assisted injection of OK-432 in lymphatic malformations by the plastic surgeon, J Plast Reconstr Aesthet Surg, 61, pp. 1269-1270, (2008)
60. Wiegand S., Et al., Microcystic lymphatic malformations of the tongue: Diagnosis, classification, and treatment, Arch Otolaryngol Head Neck Surg, 135, pp. 976-983, (2009)
61. Hong J.P., Lee M.Y., Kim E.K., Seo D.H., Giant lymphangioma of the tongue, J Craniofac Surg, 20, pp. 252-254, (2009)
62. Churchill P., Et al., Sclerotherapy for lymphatic malformations in children: A scoping review, J Pediatr Surg, 46, pp. 912-922, (2011)
63. Boghani Z., Et al., Juvenile nasopharyngeal angiofibroma: A systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases, Laryngoscope, 123, pp. 859-869, (2013)
64. Reyes C., Bentley H., Gelves J.A., Solares C.A., Byrd J.K., Recurrence rate after endoscopic vs. open approaches for juvenile nasopharyngeal angiofibroma: A meta-analysis, J Neurol Surg B Skull Base, 80, pp. 577-585, (2019)
65. Liu Z., Et al., The risk factors for residual juvenile nasopharyngeal angiofibroma and the usual residual sites, Am J Otolaryngol, 40, pp. 343-346, (2019)
66. Petruson K., Rodriguez-Catarino M., Petruson B., Finizia C., Juvenile nasopharyngeal angiofibroma:Long-term results in preoperative embolized and non-embolized patients, Acta Otolaryngol, 122, pp. 96-100, (2002)
67. Glad H., Et al., Juvenile nasopharyngeal angiofibromas in Denmark 1981-2003: Diagnosis, incidence, and treatment, Acta Otolaryngol, 127, pp. 292-299, (2007)
68. Ralli M., Et al., Nasopharyngeal angiofibroma in an elderly female patient: A rare case report, Mol Clin Oncol, 9, pp. 702-704, (2018)
69. Osborn D.A., Sokolovski A., Juvenile nasopharyngeal angiofibroma in a female. Report of a case, Arch Otolaryngol, 82, pp. 629-632, (1965)
70. Peloquin L., Et al., A rare case of nasopharyngeal angiofibroma in a pregnant woman, Otolaryngol Neck Surg, 117, pp. S111-S114, (1997)
71. Patrocinio J.A., Patrocinio L.G., Borba B.H.C., Bonatti B.D.S., Guimaraes A.H.B., Nasopharyngeal angiofibroma in an elderly woman, Am J Otolaryngol, 26, pp. 198-200, (2005)
72. Ochi J.W., Kearns D.B., Seid A.B., Pransky S.M., Krous H.F., Do angiomas of the nasal septum exist?, Int J Pediatr Otorhinolaryngol, 19, pp. 169-173, (1990)
73. Schick B., Urbschat S., New aspects of pathogenesis of juvenile angiofibroma, Hosp Med, 65, pp. 269-273, (2004)
74. Beham A., Beham-Schmid C., Regauer S., Aubock L., Stammberger H., Nasopharyngeal angiofibroma:True neoplasm or vascular malformation?, Adv Anat Pathol, 7, pp. 36-46, (2000)
75. Montag A.G., Tretiakova M., Richardson M., Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta, Am J Clin Pathol, 125, pp. 832-837, (2006)
76. Lee D.A., Rao B.R., Meyer J.S., Prioleau P.G., Bauer W.C., Hormonal receptor determination in juvenile nasopharyngeal angiofibromas, Cancer, 46, pp. 547-551, (1980)
77. Lloyd G., Howard D., Phelps P., Cheesman A., Juvenile angiofibroma: The lessons of 20 years of modern imaging, J Laryngol Otol, 113, pp. 127-134, (1999)
78. Ungkanont K., Et al., Juvenile nasopharyngeal angiofibroma: An update of therapeutic management, Head Neck, 18, pp. 60-66, (1996)
79. Makhasana J.A.S., Kulkarni M.A., Vaze S., Shroff A.S., Juvenile nasopharyngeal angiofibroma, J Oral Maxillofac Pathol, 20, (2016)
80. Andrews J.C., Fisch U., Valavanis A., Aeppli U., Makek M.S., The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach, Laryngoscope, 99, pp. 429-437, (1989)
81. Radkowski D., McGill T., Healy G.B., Ohlms L., Jones D.T., Angiofibroma. Changes in staging and treatment, Arch Otolaryngol Head Neck Surg, 122, pp. 122-129, (1996)
82. Snyderman C.H., Pant H., Carrau R.L., Gardner P., A new endoscopic staging system for angiofibromas, Arch Otolaryngol Head Neck Surg, 136, pp. 588-594, (2010)
83. Jacobsson M., Petruson B., Ruth M., Svendsen P., Involution of juvenile nasopharyngeal angiofibroma with intracranial extension. A case report with computed tomographic assessment, Arch Otolaryngol Head Neck Surg, 115, pp. 238-239, (1989)
84. Wu A.W., Mowry S.E., Vinuela F., Abemayor E., Wang M.B., Bilateral vascular supply in juvenile nasopharyngeal angiofibromas, Laryngoscope, 121, pp. 639-643, (2011)
85. Gupta A.C., Murthy D.P., Intracranial juvenile nasopharyngeal angiofibroma, Aust N Z J Surg, 67, pp. 477-482, (1997)
86. Taylor R.J., Et al., Endoscopic endonasal approaches to infratemporal fossa tumors: A classification system and case series, Laryngoscope, 124, pp. 2443-2450, (2014)
87. Cloutier T., Et al., Juvenile nasopharyngeal angiofibroma: Does the external approach still make sense?, Otolaryngol Neck Surg, 147, pp. 958-963, (2012)
88. McCombe A., Lund V.J., Howard D.J., Recurrence in juvenile angiofibroma, Rhinology, 28, pp. 97-102, (1990)
89. Thakar A., Et al., Overt and occult vidian canal involvement in juvenile angiofibroma and its possible impact on recurrence, Head Neck, pp. E421-E425, (2016)
90. Howard D.J., Lloyd G., Lund V., Recurrence and its avoidance in juvenile angiofibroma, Laryngoscope, 111, pp. 1509-1511, (2001)
91. Cummings B.J., Et al., Primary radiation therapy for juvenile nasopharyngeal angiofibroma, Laryngoscope, 94, pp. 1599-1605, (1984)
92. Fernandez K.S., de Alarcon A., Adams D.M., Hammill A.M., Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma, Pediatr Blood Cancer, 67, (2020)
93. Wasserman P.G., Savargaonkar P., Paragangliomas: Classification, pathology, and differential diagnosis, Otolaryngol Clin North Am, 34, pp. 845-862, (2001)
94. Sobol S.M., Dailey J.C., Familial multiple cervical paragangliomas: Report of a kindred and review of the literature, Otolaryngol Neck Surg, 102, pp. 382-390, (1990)
95. Boedeker C.C., Et al., Genetics of hereditary head and neck paragangliomas, Head Neck, 36, pp. 907-916, (2014)
96. Watson D.J., Nasal paraganglioma, J Laryngol Otol, 102, pp. 526-529, (1988)
97. von Dobschuetz E., Et al., A registry-based study of thyroid paraganglioma: Histological and genetic characteristics, Endocr Relat Cancer, 22, pp. 191-204, (2015)
98. Saurborn D.P., Kruskal J.B., Stillman I.E., Parangi S., Best cases from the AFIP: Paraganglioma of the organs of Zuckerkandl, Radiographics, 23, pp. 1279-1286, (2003)
99. Martins R., Bugalho M.J., Paragangliomas/Pheochromocytomas: Clinically oriented genetic testing, Int J Endocrinol, 2014, (2014)
100. Som P.M., Biller H.F., Lawson W., Tumors of the parapharyngeal space: Preoperative evaluation, diagnosis and surgical approaches, Ann Otol Rhinol Laryngol Suppl, 90, pp. 3-15, (1981)
101. Olsen W.L., Et al., MR imaging of paragangliomas, AJR Am J Roentgenol, 148, pp. 201-204, (1987)
102. Hesselink J.R., Davis K.R., Taveras J.M., Selective arteriography of glomus tympanicum and jugulare tumors: Techniques, normal and pathologic arterial anatomy, AJNR Am J Neuroradiol, 2, pp. 289-297, (1981)
103. Sajid M.S., Hamilton G., Baker D.M., A multicenter review of carotid body tumour management, Eur J Vasc Endovasc Surg, 34, pp. 127-130, (2007)
104. Shamblin W.R., ReMine W.H., Sheps S.G., Harrison E.G.J., Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases, Am J Surg, 122, pp. 732-739, (1971)
105. Arya S., Rao V., Juvekar S., Dcruz A.K., Carotid body tumors: Objective criteria to predict the Shamblin group on MR imaging, AJNR Am J Neuroradiol, 29, pp. 1349-1354, (2008)
106. Rao A.B., Koeller K.K., Adair C.F., From the archives of the AFIP. Paragangliomas of the head and neck: Radiologic-pathologic correlation. Armed Forces Institute of Pathology, Radiographics, 19, pp. 1605-1632, (1999)
107. Ayala-Ramirez M., Et al., Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: Primary tumor size and primary tumor location as prognostic indicators, J Clin Endocrinol Metab, 96, pp. 717-725, (2011)
108. Kaltsas G.A., Mukherjee J.J., Grossman A.B., The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours, Ann Oncol, pp. S47-S50, (2001)
109. Timmers H.J.L.M., Et al., Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma, J Clin Endocrinol Metab, 94, pp. 4757-4767, (2009)
110. Chang C.A., Et al., (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: Utility, patterns and heterogeneity, Cancer Imaging, 16, (2016)
111. Darr R., Et al., Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: A systematic review, Endocrine, 56, pp. 495-503, (2017)
112. van Duinen N., Et al., Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites, Eur J Endocrinol, 169, pp. 377-382, (2013)
113. Kroiss A., Et al., (68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT, Eur J Nucl Med Mol Imaging, 42, pp. 33-41, (2015)
114. Jansen J.C., Et al., Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal, Cancer, 88, pp. 2811-2816, (2000)
115. Kruger A.J., Et al., Important observations made managing carotid body tumors during a 25-year experience, J Vasc Surg, 52, pp. 1518-1523, (2010)
116. Morton R.P., Stewart T., Dray M.S., Farmilo W., A role for ipsilateral, selective neck dissection in carotid body tumours, J Laryngol Otol, 123, pp. 934-936, (2009)
117. Lenders J.W.M., Eisenhofer G., Mannelli M., Pacak K., Phaeochromocytoma, Lancet, 366, pp. 665-675, (2005)
118. Ikeda A., Et al., Multi-institutional survey of carotid body tumors in Japan, Oncol Lett, 15, pp. 5318-5324, (2018)
119. Jackson R.S., Et al., The effects of preoperative embolization on carotid body paraganglioma surgery: A systematic review and meta-analysis, Otolaryngol Neck Surg, 153, pp. 943-950, (2015)
120. Kasper G.C., Et al., A multidisciplinary approach to carotid paragangliomas, Vasc Endovasc Surg, 40, pp. 467-474, (2006)
121. Zeitler D.M., Glick J., Har-El G., Preoperative embolization in carotid body tumor surgery: Is it required?, Ann Otol Rhinol Laryngol, 119, pp. 279-283, (2010)
122. Wang S.J., Wang M.B., Barauskas T.M., Calcaterra T.C., Surgical management of carotid body tumors, Otolaryngol Neck Surg, 123, pp. 202-206, (2000)
123. LaMuraglia G.M., Et al., The current surgical management of carotid body paragangliomas, J Vasc Surg, 15, pp. 1035-1038, (1992)
124. Ward P.H., Liu C., Vinuela F., Bentson J.R., Embolization: An adjunctive measure for removal of carotid body tumors, Laryngoscope, 98, pp. 1287-1291, (1988)
125. Power A.H., Et al., Impact of preoperative embolization on outcomes of carotid body tumor resections, J Vasc Surg, 56, pp. 979-989, (2012)
126. Kohler H.F., Carvalho A.L., Mattos Granja N.V., Nishinari K., Kowalski L.P., Surgical treatment of paragangliomas of the carotid bifurcation: Results of 36 patients, Head Neck, 26, pp. 1058-1063, (2004)
127. Texakalidis P., Et al., Role of preoperative embolization in carotid body tumor surgery: A systematic review and meta-analysis, World Neurosurg, 129, pp. 503-513, (2019)
128. Gilbo P., Et al., Radiotherapy for benign head and neck paragangliomas: A 45-year experience, Cancer, 120, pp. 3738-3743, (2014)
129. Zandee W.T., Et al., Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE, Eur J Endocrinol, 181, pp. 45-53, (2019)
130. Wakabayashi H., Et al., A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma, Sci Rep, 9, (2019)
131. Gupta S.K., Singla S., Karunanithi S., Damle N., Bal C., Peptide receptor radionuclide therapy with (177)Lu DOTATATE in a case of recurrent carotid body paraganglioma with spinal metastases, Clin Nucl Med, 39, pp. 440-441, (2014)
132. Szymanska A., Szymanski M., Czekajska-Chehab E., Golabek W., Szczerbo-Trojanowska M., Diagnosis and management of multiple paragangliomas of the head and neck, Eur Arch Oto-rhino-laryngol, 272, pp. 1991-1999, (2015)
133. McNicol A.M., Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma, Histopathology, 58, pp. 155-168, (2011)
134. Lam A.K.-Y., Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours, Endocr Pathol, 28, pp. 213-227, (2017)
135. Zbaren P., Lehmann W., Carotid body paraganglioma with metastases, Laryngoscope, 95, pp. 450-454, (1985)
136. Rinaldo A., Myssiorek D., Devaney K.O., Ferlito A., Which paragangliomas of the head and neck have a higher rate of malignancy?, Oral Oncol, 40, pp. 458-460, (2004)
137. Chapman D.B., Et al., Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas, Otolaryngol Neck Surg, 143, pp. 531-537, (2010)
138. Pacak K., Et al., Radiofrequency ablation: A novel approach for treatment of metastatic pheochromocytoma, J Natl Cancer Inst, 93, pp. 648-649, (2001)
139. Mediouni A., Et al., Malignant head/neck paragangliomas. Comparative study, Eur Ann Otorhinolaryngol Head Neck Dis, 131, pp. 159-166, (2014)
140. Havekes B., Et al., Detection and treatment of pheochromocytomas and paragangliomas: Current standing of MIBG scintigraphy and future role of PET imaging, Q J Nucl Med Mol Imaging, 52, pp. 419-429, (2008)
141. Baudin E., Et al., Therapy of endocrine disease: Treatment of malignant pheochromocytoma and paraganglioma, Eur J Endocrinol, 171, pp. R111-R122, (2014)
142. Boedeker C.C., Ridder G.J., Schipper J., Paragangliomas of the head and neck: Diagnosis and treatment, Familial Cancer, 4, pp. 55-59, (2005)
143. Lustrin E.S., Palestro C., Vaheesan K., Radiographic evaluation and assessment of paragangliomas, Otolaryngol Clin North Am, 34, pp. 881-906, (2001)
144. Moe K.S., Li D., Linder T.E., Schmid S., Fisch U., An update on the surgical treatment of temporal bone paraganglioma, Skull Base Surg, 9, pp. 185-194, (1999)
145. Chen H., Et al., The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: Pheochromocytoma, paraganglioma, and medullary thyroid cancer, Pancreas, 39, pp. 775-783, (2010)
146. Li D., Et al., Less-aggressive surgical management and long-term outcomes of jugular foramen paragangliomas: A neurosurgical perspective, J Neurosurg, 125, pp. 1143-1154, (2016)
147. Sanna M., Fois P., Pasanisi E., Russo A., Bacciu A., Middle ear and mastoid glomus tumors (glomus tympanicum): An algorithm for the surgical management, Auris Nasus Larynx, 37, pp. 661-668, (2010)
148. Sanna M., Et al., Infratemporal fossa approach type a with transcondylar-transtubercular extension for Fisch type C2 to C4 tympanojugular paragangliomas, Head Neck, 36, pp. 1581-1588, (2014)
149. Jackson C.G., Et al., Lateral skull base surgery for glomus tumors: Long-term control, Otol Neurotol, 22, pp. 377-382, (2001)
150. Fisch U., The infratemporal fossa approach for nasopharyngeal tumors, Laryngoscope, 93, pp. 36-44, (1983)
151. Krych A.J., Foote R.L., Brown P.D., Garces Y.I., Link M.J., Long-term results of irradiation for paraganglioma, Int J Radiat Oncol Biol Phys, 65, pp. 1063-1066, (2006)
152. Marchetti M., Et al., Radiosurgery for paragangliomas of the head and neck: Another step for the validation of a treatment paradigm, World Neurosurg, 98, pp. 281-287, (2017)
153. de Cubas A.A., Et al., DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers, Clin Cancer Res, 21, pp. 3020-3030, (2015)
154. Burnichon N., Buffet A., Gimenez-Roqueplo A.-P., Pheochromocytoma and paraganglioma:Molecular testing and personalized medicine, Curr Opin Oncol, 28, pp. 5-10, (2016)
155. Crona J., Et al., Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing, J Clin Endocrinol Metab, 98, pp. E1266-E1271, (2013)
156. Favier J., Amar L., Gimenez-Roqueplo A.-P., Paraganglioma and phaeochromocytoma: From genetics to personalized medicine, Nat Rev Endocrinol, 11, pp. 101-111, (2015)
157. Pasini B., Stratakis C.A., SDH mutations in tumorigenesis and inherited endocrine tumours: Lesson from the phaeochromocytoma-paraganglioma syndromes, J Intern Med, 266, pp. 19-42, (2009)
158. Neumann H.P.H., Eng C., The approach to the patient with paraganglioma, J Clin Endocrinol Metab, 94, pp. 2677-2683, (2009)
159. Burnichon N., Et al., The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas, J Clin Endocrinol Metab, 94, pp. 2817-2827, (2009)
160. Klein R.D., Jin L., Rumilla K., Young W.F.J., Lloyd R.V., Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas, Diagn Mol Pathol, 17, pp. 94-100, (2008)
161. Amar L., Et al., Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas, J Clin Endocrinol Metab, 92, pp. 3822-3828, (2007)
162. Korpershoek E., Et al., SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas, J Clin Endocrinol Metab, 96, pp. E1472-E1476, (2011)
163. Offergeld C., Et al., Head and neck paragangliomas: Clinical and molecular genetic classification, Clinics, pp. 19-28, (2012)
164. Petr E.J., Else T., Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: Frequent surgeries and cardiovascular crises indicate the need for screening, Clin Diabetes Endocrinol, 4, (2018)
165. Carney J.A., The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: A five-year review, Medicine, 62, pp. 159-169, (1983)
166. Eisenhofer G., Et al., Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma, Am J Physiol Endocrinol Metab, 295, pp. E1223-E1233, (2008)
167. Tella S.H., Taieb D., Pacak K., HIF-2alpha: Achilles’ heel of pseudohypoxic subtype paraganglioma and other related conditions, Eur J Cancer, 86, pp. 1-4, (2017)
168. Havekes B., Et al., Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas, Endocr Relat Cancer, 16, pp. 527-536, (2009)
169. Tufton N., Sahdev A., Akker S.A., Radiological surveillance screening in asymptomatic succinate dehydrogenase mutation carriers, J Endocr Soc, 1, pp. 897-907, (2017)
170. Pallin D.J., Et al., Epidemiology of epistaxis in US emergency departments, 1992 to 2001, Ann Emerg Med, 46, pp. 77-81, (2005)
171. Manfredini R., Portaluppi F., Salmi R., Martini A., Gallerani M., Circadian variation in onset of epistaxis: Analysis of hospital admissions, BMJ, 321, (2000)
172. Tomkinson A., Roblin D.G., Flanagan P., Quine S.M., Backhouse S., Patterns of hospital attendance with epistaxis, Rhinology, 35, pp. 129-131, (1997)
173. Beran M., Petruson B., Occurrence of epistaxis in habitual nose-bleeders and analysis of some etiological factors, ORL J Otorhinolaryngol Relat Spec, 48, pp. 297-303, (1986)
174. Girsh L.S., Allergic rhinitis, a common cause of recurrent epistaxis in children, AMA J Dis Child, 99, pp. 819-821, (1960)
175. Snyderman C.H., Goldman S.A., Carrau R.L., Ferguson B.J., Grandis J.R., Endoscopic sphenopalatine artery ligation is an effective method of treatment for posterior epistaxis, Am J Rhinol, 13, pp. 137-140, (1999)
176. Krulewitz N.A., Fix M.L., Epistaxis, Emerg Med Clin North Am, 37, pp. 29-39, (2019)
177. Abrich V., Brozek A., Boyle T.R., Chyou P.-H., Yale S.H., Risk factors for recurrent spontaneous epistaxis, Mayo Clin Proc, 89, pp. 1636-1643, (2014)
178. Daudia A., Jaiswal V., Jones N.S., Guidelines for the management of idiopathic epistaxis in adults: How we do it, Clin Otolaryngol, 33, pp. 618-620, (2008)
179. George A., Smatanova K., Joshi H., Jervis S., Oluwole M., Sphenopalatine, anterior ethmoid and internal maxillary artery intervention in the management of refractory epistaxis: Their efficacy in 25 patients, Clini Otolaryngol, 37, pp. 321-325, (2012)
180. Carey B., Sheahan P., Aetiological profile and treatment outcomes of epistaxis at a major teaching hospital: A review of 721 cases, Ir J Med Sci, 187, pp. 761-766, (2018)
181. Kumar S., Shetty A., Rockey J., Nilssen E., Contemporary surgical treatment of epistaxis. What is the evidence for sphenopalatine artery ligation?, Clin Otolaryngol Allied Sci, 28, pp. 360-363, (2003)
182. Nair K.K., Transantral ligation of the internal maxillary artery, Laryngoscope, 92, pp. 1060-1063, (1982)
183. Stamm A.C., Pinto J.A., Neto A.F., Menon A.D., Microsurgery in severe posterior epistaxis, Rhinology, 23, pp. 321-325, (1985)
184. Budrovich R., Saetti R., Microscopic and endoscopic ligature of the sphenopalatine artery, Laryngoscope, 102, pp. 1391-1394, (1992)
185. de Almeida G.S., Diogenes C.A., Pinheiro S.D., Nasal endoscopy and localization of the bleeding source in epistaxis: Last decade’s revolution, Braz J Otorhinolaryngol, 71, pp. 146-148, (2005)
186. Kosugi E.M., Et al., Breaking paradigms in severe epistaxis: The importance of looking for the S-point, Braz J Otorhinolaryngol, 84, pp. 290-297, (2018)
187. Gede L.L., Aanaes K., Collatz H., Larsen P.L., von Buchwald C., National long-lasting effect of endonasal endoscopic sphenopalatine artery clipping for epistaxis, Acta Otolaryngol, 133, pp. 744-748, (2013)
188. de Bonnecaze G., Et al., Transnasal endoscopic sphenopalatine artery ligation compared with embolization for intractable epistaxis: A long-term analysis, Am J Rhinol Allergy, 32, pp. 188-193, (2018)
189. Christensen N.P., Smith D.S., Barnwell S.L., Wax M.K., Arterial embolization in the management of posterior epistaxis, Otolaryngol Neck Surg, 133, pp. 748-753, (2005)
190. Cullen M.M., Tami T.A., Comparison of internal maxillary artery ligation versus embolization for refractory posterior epistaxis, Otolaryngol Neck Surg, 118, pp. 636-642, (1998)
191. Brinjikji W., Kallmes D.F., Cloft H.J., Trends in epistaxis embolization in the United States: A study of the Nationwide Inpatient Sample 2003-2010, J Vasc Interv Radiol, 24, pp. 969-973, (2013)
192. Katsevman G.A., Braca J.A., Welch K.C., Ashley W.W.J., Delayed presentation of an extracranial internal carotid artery pseudoaneurysm and massive epistaxis secondary to a nasal foreign body: Case report and review of the literature, World Neurosurg, 92, (2016)
193. Maran A.G., Amin M., Wilson J.A., Radical neck dissection: A 19-year experience, J Laryngol Otol, 103, pp. 760-764, (1989)
194. Haapio E., Kinnunen I., Airaksinen J.K.E., Irjala H., Kiviniemi T., Determinants of re-operation for bleeding in head and neck cancer surgery, J Laryngol Otol, 132, pp. 336-340, (2018)
195. Chan J.Y.W., To V.S.H., Wong S.T.S., Wei W.I., Quality of dying in head and neck cancer patients:The role of surgical palliation, Eur Arch Oto-rhino-laryngol, 270, pp. 681-688, (2013)
196. Powitzky R., Vasan N., Krempl G., Medina J., Carotid blowout in patients with head and neck cancer, Ann Otol Rhinol Laryngol, 119, pp. 476-484, (2010)
197. Liang N.L., Et al., Outcomes of interventions for carotid blowout syndrome in patients with head and neck cancer, J Vasc Surg, 63, pp. 1525-1530, (2016)